Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 19Terminated 7Unknown 3Active not recruiting 3Withdrawn 2Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

pembrolizumab 439Carboplatin 323Nivolumab 291Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 254Paclitaxel 249Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 169atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Radiosurgery 114Oxaliplatin 114Pemetrexed 113Etoposide 111Fluorouracil 110venetoclax 108fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Fatty Acids, Omega-3 × Clear all
NCT02295059 2026-04-03

Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention

City of Hope Medical Center

Phase NA Active not recruiting
80 enrolled
Breast

Breast Neoplasms

NCT01169259 2025-11-06

VITAL

Brigham and Women's Hospital

Phase 3 Active not recruiting
25,871 enrolled 38 charts

Cardiovascular Diseases, Neoplasms

NCT02176902 2025-02-10

Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer

Jonsson Comprehensive Cancer Center

Phase NA Active not recruiting
107 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡